US Stock MarketDetailed Quotes

Gain Therapeutics (GANX)

Watchlist
  • 1.830
  • +0.050+2.81%
Trading May 14 14:14 ET
78.06MMarket Cap-3.16P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Gain Therapeutics (GANX) Revenue Breakdown Overview

By Business/Source

Currency:USD
2023/FY
Stock NameRevenueRatio
Research and development in the pharmaceutical sector with a focus on developing novel therapeutics55.18K100.00%

By Country/Region

Currency:USD
2023/FY
Stock NameRevenueRatio
United States55.18K100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.60%
Sample Name
Sample Code
 +14.41%
Sample Name
Sample Code
 +13.74%
4
United States Oil Fund LP
USO
+12.79%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+10.45%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +13.52%
Sample Name
Sample Code
 +9.40%
Sample Name
Sample Code
 +9.05%
4
Hesai
HSAI
+8.10%
5
NIO Inc
NIO
+7.33%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -